The impact of a hematocrit of 20% during normothermic cardiopulmonary bypass for elective coronary artery bypass graft surgery on oxygen delivery and clinical outcome: a randomised controlled study
Completed
- Conditions
- Coronary artery disease requiring surgical revascularisationCirculatory SystemCoronary artery disease
- Registration Number
- ISRCTN35655335
- Lead Sponsor
- Charité - University Medicine Berlin (Charité - Universitätsmedizin Berlin) (Germany)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Coronary artery disease patients to about to undergo coronary artery bypass graft surgery.
Exclusion Criteria
1. Ejection fraction less than 40%
2. Chronic Obstructive Pulmonary Disease (COPD)
3. Renal insufficiency
4. Peripheral artery disease
5. Hepatic dysfunction
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Oxygen delivery and oxygen consumption.
- Secondary Outcome Measures
Name Time Method 1. Myocardial infarction<br>2. Renal insufficiency measured as creatinine and urine volume<br>3. Neurological deficits displayed as agitated arousal reactions and stroke